StockData
Syndax Pharmaceuticals Inc logo

Syndax Pharmaceuticals Inc (SNDX) stock

SNDXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 2, 2026Score 3/30
$9.20+0.07 (+0.77%)

Close on Nov 17, 2026Market cap $821.53MP/E –Yield –

Syndax Pharmaceuticals price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

Syndax Pharmaceuticals's price to book ratio was 56.6× on Nov 11, 2026, against 14.9× a year earlier. Over the last 5 years it ranged from 2.1× to 113.9×, with a median of 3.9×.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 202656.6×+40.8
2025Dec 31, 202515.8×+12.7
2024Dec 31, 20243.1×−1.1
2023Dec 29, 20234.2×−0.3
2022Dec 30, 20224.5×−0.8
2021Dec 31, 20215.4×−1.2
2020Dec 31, 20206.5×+1.1
2019Dec 31, 20195.4×+3.7
2018Dec 31, 20181.7×−0.4
2017Dec 29, 20172.0×+0.6
2016Dec 30, 20161.4×–

More Syndax Pharmaceuticals figures

See a number that looks wrong?